Equillium, Inc. (EQ)
2.385
-0.06
(-2.65%)
USD |
NASDAQ |
Aug 28, 16:00
2.385
0.00 (0.00%)
After-Hours: 19:31
Equillium Cash from Operations (Quarterly) : -4.107M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.107M |
| March 31, 2026 | -4.301M |
| December 31, 2025 | -3.133M |
| September 30, 2025 | -8.431M |
| June 30, 2025 | -3.013M |
| March 31, 2025 | -8.169M |
| December 31, 2024 | -3.299M |
| September 30, 2024 | -7.657M |
| June 30, 2024 | 0.73M |
| March 31, 2024 | -8.80M |
| December 31, 2023 | -5.664M |
| September 30, 2023 | -1.909M |
| June 30, 2023 | -6.215M |
| March 31, 2023 | -7.995M |
| December 31, 2022 | 27.72M |
| September 30, 2022 | -13.06M |
| June 30, 2022 | -11.26M |
| Date | Value |
|---|---|
| March 31, 2022 | -12.13M |
| December 31, 2021 | -10.13M |
| September 30, 2021 | -7.01M |
| June 30, 2021 | -6.994M |
| March 31, 2021 | -7.944M |
| December 31, 2020 | -8.253M |
| September 30, 2020 | -4.921M |
| June 30, 2020 | -5.08M |
| March 31, 2020 | -6.37M |
| December 31, 2019 | -9.033M |
| September 30, 2019 | -4.696M |
| June 30, 2019 | -4.756M |
| March 31, 2019 | -4.464M |
| December 31, 2018 | -3.827M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -0.889M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Fortress Biotech, Inc. | -59.28M |
| Cue Biopharma, Inc. | -29.00M |
| Legend Biotech Corp. | -20.87M |
| Dianthus Therapeutics, Inc. | -48.98M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.071M |
| Cash from Financing (Quarterly) | 0.042M |
| Free Cash Flow | -20.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0374 |
| Free Cash Flow to Equity (Quarterly) | -4.07M |
| Free Cash Flow to Firm (Quarterly) | -4.178M |
| Free Cash Flow Yield | -9.22% |